Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.37
(2.82%)
HKD 0.37
(2.82%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 55.64 Million CNY | -29.21% |
| 2022 | 78.6 Million CNY | 34.17% |
| 2021 | 58.58 Million CNY | -21.29% |
| 2020 | 74.42 Million CNY | 37.18% |
| 2019 | 54.25 Million CNY | 10.29% |
| 2018 | 49.19 Million CNY | 20.99% |
| 2017 | 40.66 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 32.36 Million CNY | 0.0% |
| 2024 Q1 | 32.36 Million CNY | -41.84% |
| 2023 Q1 | 40.32 Million CNY | -48.69% |
| 2023 FY | 55.64 Million CNY | -29.21% |
| 2023 Q4 | 55.64 Million CNY | 13.82% |
| 2023 Q3 | 48.88 Million CNY | 5.3% |
| 2023 Q2 | 46.42 Million CNY | 15.12% |
| 2022 Q1 | 50.06 Million CNY | -14.53% |
| 2022 Q4 | 78.6 Million CNY | 7.15% |
| 2022 FY | 78.6 Million CNY | 34.17% |
| 2022 Q2 | 50.06 Million CNY | 0.0% |
| 2022 Q3 | 73.35 Million CNY | 46.51% |
| 2021 Q4 | 58.58 Million CNY | 0.0% |
| 2021 Q3 | 58.58 Million CNY | 23.88% |
| 2021 Q2 | 47.29 Million CNY | 0.0% |
| 2021 FY | 58.58 Million CNY | -21.29% |
| 2021 Q1 | 47.29 Million CNY | -36.46% |
| 2020 Q4 | 74.42 Million CNY | 36.76% |
| 2020 FY | 74.42 Million CNY | 37.18% |
| 2020 Q3 | 54.41 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 54.25 Million CNY | 0.0% |
| 2019 FY | 54.25 Million CNY | 10.29% |
| 2018 FY | 49.19 Million CNY | 20.99% |
| 2017 FY | 40.66 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 12.02 Billion HKD | 99.537% |